Cargando…

A Variant in Genes of the NPY System as Modifier Factor of Machado-Joseph Disease in the Chinese Population

Recently, NPY overexpression has been proposed to alleviate motor deficits and neuropathy in Machado-Joseph disease (MJD) mouse models, indicating its neuroprotective role in the pathogenesis of MJD. We aimed to evaluate the association between SNPs in NPY and its receptors and the susceptibility of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ding, Dongxue, Chen, Zhao, Wang, Chunrong, Tang, Xiang, Zhang, Lulu, Fang, Qi, Qiu, Rong, Jiang, Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Aging Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8851415/ https://www.ncbi.nlm.nih.gov/pubmed/35185528 http://dx.doi.org/10.3389/fnagi.2022.822657

Ejemplares similares

Neuropeptide Y (NPY) intranasal delivery alleviates Machado–Joseph disease
por: Duarte-Neves, Joana, et al.
Publicado: (2021)

Is the High Frequency of Machado-Joseph Disease in China Due to New Mutational Origins?
por: Li, Tianjiao, et al.
Publicado: (2019)

Ataxin-3 and Its E3 Partners: Implications for Machado–Joseph Disease
por: Durcan, Thomas M., et al.
Publicado: (2013)

Peripheral Oxidative Stress Biomarkers in Spinocerebellar Ataxia Type 3/Machado–Joseph Disease
por: de Assis, Adriano M., et al.
Publicado: (2017)

Familial spontaneous pneumothorax and Machado–Joseph disease
por: Pelayo, Jerald, et al.
Publicado: (2020)

Normal ATXN3 Allele but Not CHIP Polymorphisms Modulates Age at Onset in Machado–Joseph Disease
por: França, Marcondes C., et al.
Publicado: (2012)

Cerebellar Rotation Abnormalities Observed in Machado-Joseph Disease
por: Nomura, Taichi, et al.
Publicado: (2020)

Cerebellar morphometric and spectroscopic biomarkers for Machado-Joseph Disease
por: Miranda, Catarina Oliveira, et al.
Publicado: (2022)

Tissue-Specific Vulnerability to Apoptosis in Machado-Joseph Disease
por: Ferreira, Ana F., et al.
Publicado: (2023)

Implications of specific lysine residues within ataxin-3 for the molecular pathogenesis of Machado-Joseph disease
por: Pereira Sena, Priscila, et al.
Publicado: (2023)

High frequency of Machado-Joseph disease identified in Southeastern Chinese kindreds with spinocerebellar ataxia
por: Gan, Shi-Rui, et al.
Publicado: (2010)

Machado-Joseph Disease: from first descriptions to new perspectives
por: Bettencourt, Conceição, et al.
Publicado: (2011)

Fibroblasts of Machado Joseph Disease patients reveal autophagy impairment
por: Onofre, Isabel, et al.
Publicado: (2016)

Trehalose alleviates the phenotype of Machado–Joseph disease mouse models
por: Santana, Magda M., et al.
Publicado: (2020)

Profiling Microglia in a Mouse Model of Machado–Joseph Disease
por: Campos, Ana Bela, et al.
Publicado: (2022)

T2-hyperintensity in the internal globus pallidus in Machado-Joseph disease
por: Meira, Alex T., et al.
Publicado: (2023)

Development of stroke predictive model in community-dwelling population: A longitudinal cohort study in Southeast China
por: Wang, Qi, et al.
Publicado: (2022)

GST-4-Dependent Suppression of Neurodegeneration in C. elegans Models of Parkinson’s and Machado-Joseph Disease by Rapeseed Pomace Extract Supplementation
por: Pohl, Franziska, et al.
Publicado: (2019)

Impact of glycosylated hemoglobin on early neurological deterioration in acute mild ischemic stroke patients treated with intravenous thrombolysis
por: Han, Lin, et al.
Publicado: (2023)

Clinical manifestations and gene mutation in a case of Machado-Joseph disease★
por: Zhang, Bin, et al.
Publicado: (2012)

State biomarkers for Machado Joseph disease: Validation, feasibility and responsiveness to change
por: Furtado, Gabriel Vasata, et al.
Publicado: (2019)

Machado-Joseph Deubiquitinases: From Cellular Functions to Potential Therapy Targets
por: Zeng, Chenming, et al.
Publicado: (2020)

Sentinel Node Biopsy and Lumpectomy in a Patient with Machado–Joseph Disease
por: Aldawoodi, N. N., et al.
Publicado: (2019)

Genome-wide association study identifies genetic factors that modify age at onset in Machado-Joseph disease
por: Akçimen, Fulya, et al.
Publicado: (2020)

Nystagmus as an early ocular alteration in Machado-Joseph disease (MJD/SCA3)
por: Raposo, Mafalda, et al.
Publicado: (2014)

Dystonia in Patients with Spinocerebellar Ataxia 3 - Machado-Joseph disease: An Underestimated Diagnosis?
por: Catai, Ligia Maria Perrucci, et al.
Publicado: (2018)

The Homogeneous Azorean Machado-Joseph Disease Cohort: Characterization and Contributions to Advances in Research
por: Lima, Manuela, et al.
Publicado: (2023)

What is the best way to keep walking and moving around for individuals with Machado-Joseph disease? A scoping review through the lens of Aboriginal families with Machado-Joseph disease in the Top End of Australia
por: Carr, Jennifer J, et al.
Publicado: (2019)

Machado-Joseph disease in a Sudanese family links East Africa to Portuguese families and allows reestimation of ancestral age of the Machado lineage
por: Martins, Sandra, et al.
Publicado: (2023)

The Machado–Joseph Disease Deubiquitinase Ataxin-3 Regulates the Stability and Apoptotic Function of p53
por: Liu, Hongmei, et al.
Publicado: (2016)

Gabapentin for complex regional pain syndrome in Machado-Joseph disease: a case report
por: Lo, Yang-Ching, et al.
Publicado: (2011)

Neural correlates of ataxia severity in spinocerebellar ataxia type 3/Machado-Joseph disease
por: Hernandez-Castillo, Carlos R., et al.
Publicado: (2017)

Development of an AAV-Based MicroRNA Gene Therapy to Treat Machado-Joseph Disease
por: Martier, Raygene, et al.
Publicado: (2019)

Remote Measurement of Functional Status in Pre-symptomatic and Symptomatic Individuals with Machado-Joseph Disease
por: Miglorini, Elaine Cristina, et al.
Publicado: (2022)

Recurrent divergence-insufficiency esotropia in Machado-Joseph disease (spinocerebellar ataxia type 3)
por: Stallworth, Jeannette Y., et al.
Publicado: (2022)

Mitochondrial Dysfunction and Decreased Cytochrome c in Cell and Animal Models of Machado–Joseph Disease
por: Almeida, Filipa, et al.
Publicado: (2023)

The Role of Apolipoprotein E as a Risk Factor for an Earlier Age at Onset for Machado-Joseph Disease Is Doubtful
por: Zhou, Qi, et al.
Publicado: (2014)

Parkinsonian phenotype in Machado-Joseph disease (MJD/SCA3): a two-case report
por: Bettencourt, Conceição, et al.
Publicado: (2011)

Genetic counseling and presymptomatic testing programs for Machado-Joseph Disease: lessons from Brazil and Portugal
por: Schuler-Faccini, Lavínia, et al.
Publicado: (2014)

Limited Effect of Chronic Valproic Acid Treatment in a Mouse Model of Machado-Joseph Disease
por: Esteves, Sofia, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_g13qm5lnaan87d4jddeuhjdv75